Search All News
Residents of some NYC public housing developments can get free vision screening and eye exams in their building as part of a new study led by Columbia University’s Department of Ophthalmology.
Treatments for a rare retinal disease may be on the horizon after a new study identifies gene variants that cause a metabolic deficiency in the eye.
A clinical trial to test a gene therapy for some patients with dry age-related macular degeneration—a leading cause of blindness in the United States—is underway at Columbia and NewYork-Presbyterian.
Simon John, PhD, professor of ophthalmology, has been awarded the Sanford and Susan Greenberg Visionary Prize for his research on glaucoma.
- May 30, 2017
Researchers report that CRISPR-Cas9 gene-editing technology can introduce hundreds of unintended mutations into the genome.
- April 19, 2017
New genetic findings should help researchers uncover how MacTel, a disease of the retina, develops and how to design therapies to prevent loss of vision.
- November 14, 2016
Columbia University researchers slowed vision loss in mice who have a form of retinitis pigmentosa by reprogramming the metabolism of photoreceptors in the retina.
- November 5, 2015
Eye damage from high-power lasers can masquerade as genetic eye diseases and lead to costly work-ups, Columbia ophthalmologists find.
- July 10, 2014
Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa, a leading cause of vision loss.
- April 23, 2014
Dr. Janet Sparrow and colleagues are pioneering a new way to use the retina's natural fluorescence to track and characterize the progression of eye diseases.
- April 9, 2014
Important tips on sunglasses and sun exposure from NewYork-Presbyterian Hospital experts.
- March 26, 2014
Early detection of retinoblastoma in children does not improve outcomes, suggests a Mailman study.